News
Lupus LA is proud to announce the 2025 Patient Advocacy Panel, welcoming two new patient leaders to further amplify diverse voices and lived experiences within the lupus community. The new ...
AUGUSTA, GA (WJBF)- Lupus warriors across the CSRA are coming together to share knowledge for lupus and mental health awareness month, hoping to save lives. “Often times the reality is there’s ...
Lupus anticoagulant (LAC) may serve as a potential biomarker of cardiac dysfunction in patients with systemic lupus erythematosus (SLE), according to study findings published in the Journal of ...
SAN MATEO, Calif., Nov. 7, 2023 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of ...
Any presence of lupus anticoagulant (LAC) Moderate to high titers of anti-cardiolipin antibodies (aCL) Moderate to high titers of anti-β 2 glycoprotein I antibodies (aβ 2 GPI), either IgG or IgM ...
GlaxoSmithKline <GSK.L> shares gain 2 percent following backing from a U.S. advisory panel for its lupus drug Benlysta, which is seen as a potential blockbuster. Glaxo will share profits on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results